Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rationale, design, and protocol for a sequential, multiple assignment, randomized trial of adaptive treatment for smoking cessation: The ADAPT trial

Contemporary Clinical Trials(2026)10.1016/j.cct.2026.108215Source: DataRank Database

Rationale, design, and protocol for a sequential, multiple assignment, randomized trial of adaptive treatment for smoking cessation: The ADAPT trial is a research paper published in Contemporary Clinical Trials (2026). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

William C. McCamy,Danielle I. King,Anna C. Ferreira,Amy E. Wahlquist ORCID,John Kaczmar

Live enrichment

PubMed:41500497 PMC:PMC13150832 OpenAlex:https://openalex.org/W7119049647

National Cancer Institute Division of Cancer Epidemiology and Genetics

Grant: R01CA284649

National Cancer Institute

FWCI

0.00

Citation Percentile

0.0%

greenLicense: cc-by-nc-nd

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13150832/

publisherhttps://api.elsevier.com/content/article/PII:S1551714426000017?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1551714426000017?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cct.2026.108215

Fields of Study

Smoking Behavior and CessationAdvanced Causal Inference TechniquesStatistical Methods in Clinical TrialsHumansSmoking CessationNicotine Replacement TherapyVareniclineSouth CarolinaSmoking Cessation AgentsRandomized Controlled Trials as TopicElectronic Nicotine Delivery SystemsAdaptive Clinical Trials as TopicAlabamaResearch DesignBupropionAdultTobacco Use Cessation Devices

MeSH Terms

VareniclineAdaptive Clinical Trials as TopicSmoking Cessation AgentsNicotine Replacement TherapyAdultAlabamaFemaleHumansMaleMiddle AgedResearch DesignSouth CarolinaRandomized Controlled Trials as TopicSmoking CessationBupropionTobacco Use Cessation DevicesElectronic Nicotine Delivery Systems

Keywords

Randomized controlled trialProtocol (science)Smoking cessationClinical trialMEDLINEIntention-to-treat analysisN of 1 trialTobaccoTreatmentHealthcare Decision Making

Sustainable Development Goals

SDG 0: Good health and well-being

Rationale, design, and protocol for a sequential, multiple assignment, randomized trial of adaptive treatment for smoking cessation: The ADAPT trial

FAIR Checklist

Authors (9)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)